Skip to main content
Jon Giles, MD, Rheumatology, Los Angeles, CA

Jon Tyler Giles MD MPH


Columbia University College of Physicians & Surgeons

Join to View Full Profile
  • 8723 Alden DrLos Angeles, CA 90048

  • Phone+1 310-423-6257

  • Fax+1 310-423-6287

Dr. Giles is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • Johns Hopkins University
    Johns Hopkins UniversityFellowship, Rheumatology, 2002 - 2004
  • University of California (San Diego) Medical Center
    University of California (San Diego) Medical CenterResidency, Internal Medicine, 1998 - 2001
  • Vanderbilt University School of Medicine
    Vanderbilt University School of MedicineClass of 1998

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2024 - 2026
  • NY State Medical License
    NY State Medical License 2010 - 2024
  • MD State Medical License
    MD State Medical License 2004 - 2012
  • Rheumatology
    American Board of Internal Medicine Rheumatology

Awards, Honors, & Recognition

  • Fellow American College of Rheumatology

Publications & Presentations

PubMed

Journal Articles

  • Amygdalar Metabolic Activity Independently Associates with Progression of Visceral Adiposity  
    Steven K Grinspoon, Janet Lo, Jon T Giles, Lisa M Shin, Karestan C Koenen, Roger K Pitman, Ahmed Tawakol, The Journal of Clinical Endocrinology and Metabolism

Press Mentions

  • Basic & Clinical Research Conference to Explore Dynamics of Inflammation and Cardiovascular Risk
    Basic & Clinical Research Conference to Explore Dynamics of Inflammation and Cardiovascular RiskNovember 8th, 2024
  • Statin Use Key to Reducing CV Risk in Rheumatoid Arthritis Patients on Tofacitinib: ORAL Surveillance Analysis
    Statin Use Key to Reducing CV Risk in Rheumatoid Arthritis Patients on Tofacitinib: ORAL Surveillance AnalysisSeptember 24th, 2023
  • ACR 2022: The Safety of JAK Inhibitors in Rheumatology
    ACR 2022: The Safety of JAK Inhibitors in RheumatologyNovember 26th, 2022
  • Join now to see all

Grant Support

  • Neuroimaging Measures of Psychosocial Stress as Predictors of Articular and Arterial Inflammation, Cardiometabolic Disease, and Treatment Response in Rheumatoid ArthritisCOLUMBIA UNIVERSITY HEALTH SCIENCES2021–2027
  • Determinats Of Body Composition In Rheumatoid ArthritisNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2010
  • Determinats Of Body Composition In Rheumatoid ArthritisNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2006–2009

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: